What does this research mean for the field?

Mechanism-informed pharmacotherapy for obstructive sleep apnea is clinically credible, but achieving true endotype-guided treatment requires scalable bedside endotyping, improved tolerability, and trait-stratified trials. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To synthesize the mechanistic rationale and current clinical trial evidence for targeting the four distinct physiological endotypes of obstructive sleep apnea with drug therapy.

August 30, 2026PharmaceuticalsOpen Access

Precision Pharmacotherapy for Obstructive Sleep Apnea: Matching Targeted Drugs to Patient Endophenotypes

View Full Paper

Ask AI

Bookmark

Authors

JOJayoung Oh JCJi Ho Choi

Discussion

Member takes

Overview

Narrative review reveals emerging pharmacotherapies targeting physiological traits in obstructive sleep apnea, suggesting trait-stratified trials are essential for true precision medicine.

Key Points

To synthesize the mechanistic rationale and current clinical trial evidence for targeting the four distinct physiological endotypes of obstructive sleep apnea with drug therapy.
Searched PubMed/MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials for literature published from January 2000 to February 2026.
Identified and narratively appraised randomized controlled trials, meta-analyses, and mechanistic endotyping studies addressing pharmacological targets in obstructive sleep apnea.
Tirzepatide gained regulatory approval for obstructive sleep apnea by promoting weight loss to reduce mechanical airway loading.
The noradrenergic–antimuscarinic combination AD109 met its phase 3 primary endpoint by activating pharyngeal dilators independently of weight, achieving a modest placebo-corrected AHI reduction of −4.0 events/h, though adverse event discontinuation was 21.2% versus 3.1% for placebo.
Carbonic anhydrase inhibitors (acetazolamide, sultiame) and select sedatives target high loop gain and low arousal thresholds, but remain tested primarily in clinically defined rather than endotype-selected cohorts.

Cite This Study

Oh et al. (2026) studied this question.

synapsesocial.com/papers/6a93f0a36c1a8fb52e79cede https://doi.org/10.3390/ph19091361

View Full Paper

Ask AI

Bookmark

August 30, 2026PharmaceuticalsOpen Access

Precision Pharmacotherapy for Obstructive Sleep Apnea: Matching Targeted Drugs to Patient Endophenotypes

View Full Paper

Ask AI

Bookmark

Authors

JOJayoung Oh JCJi Ho Choi

Discussion

Member takes

Overview

Narrative review reveals emerging pharmacotherapies targeting physiological traits in obstructive sleep apnea, suggesting trait-stratified trials are essential for true precision medicine.

Key Points

To synthesize the mechanistic rationale and current clinical trial evidence for targeting the four distinct physiological endotypes of obstructive sleep apnea with drug therapy.
Searched PubMed/MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials for literature published from January 2000 to February 2026.
Identified and narratively appraised randomized controlled trials, meta-analyses, and mechanistic endotyping studies addressing pharmacological targets in obstructive sleep apnea.
Tirzepatide gained regulatory approval for obstructive sleep apnea by promoting weight loss to reduce mechanical airway loading.
The noradrenergic–antimuscarinic combination AD109 met its phase 3 primary endpoint by activating pharyngeal dilators independently of weight, achieving a modest placebo-corrected AHI reduction of −4.0 events/h, though adverse event discontinuation was 21.2% versus 3.1% for placebo.
Carbonic anhydrase inhibitors (acetazolamide, sultiame) and select sedatives target high loop gain and low arousal thresholds, but remain tested primarily in clinically defined rather than endotype-selected cohorts.

Cite This Study

Oh et al. (2026) studied this question.

synapsesocial.com/papers/6a93f0a36c1a8fb52e79cede https://doi.org/10.3390/ph19091361

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark